Interaction databaseSupplement × PrescriptionReviewed May 2026

Fluvoxamine and Melatonin, a caution.

Fluvoxamine is a potent CYP1A2 inhibitor, and melatonin is metabolized almost entirely by CYP1A2. Coadministration raises melatonin AUC about 17-fold and peak concentration about 12-fold in healthy volunteers. The result is exaggerated, prolonged sedation, hangover effects the next day, and unpredictable shifts in sleep-wake timing.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Fluvoxamine and Melatonin
Pair type
Caution
Evidence (highest tier)
Strong
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Strong evidence

Caution

What is happening. Fluvoxamine is a potent CYP1A2 inhibitor, and melatonin is metabolized almost entirely by CYP1A2. Coadministration raises melatonin AUC about 17-fold and peak concentration about 12-fold in healthy volunteers. The result is exaggerated, prolonged sedation, hangover effects the next day, and unpredictable shifts in sleep-wake timing.

Mechanism. Fluvoxamine strongly inhibits hepatic CYP1A2, the enzyme responsible for the first metabolic step of melatonin (6-hydroxylation). Inhibition prevents first-pass and systemic clearance, producing a roughly 17-fold rise in melatonin AUC.

Recommendation. Avoid melatonin while on fluvoxamine. If a sleep aid is needed, talk to your prescriber about non-melatonin options. Even small melatonin doses (0.3-1 mg) can produce supratherapeutic blood levels in this combination.

Sources (2)
  1. Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1-6. PMID 10668847
  2. Grözinger M, Härtter S, Wang X, Röschke J, Hiemke C, Rose DM. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile. Arch Gen Psychiatry. 2000;57(8):812-3. PMID 10920471

Stack Score

How this pair moves the number.

Effect on the composite score

If both Fluvoxamine and Melatonin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.